✦ LIBER ✦

Combination chemotherapy in metastatic malignant melanoma. A randomized study of three DTIC-containing combinations

✍ Scribed by Robert E. Wittes; Janet T. Wittes; Robert B. Golbey

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 524 KB
Volume: 41
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197802)41:2<415::aid-cncr2820410206>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of BELD combination chemotherapy

The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma

✍ David W. Young; Rosemary S. Lever; JOHN S. C. English; Rona M. Mackie 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

A randomized comparison of cyclophospham

A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma

✍ Cary A. Presant; Alfred A. Bartolucci; Charles Balch; MICHAEL TRONER; MD AND THE 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Results of a randomized study comparing

Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma

✍ Mary E. Costanza; Larry Nathanson; William G. Costello; Janet Wolter; S. Fred Br 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

Combination chemotherapy in metastatic c

Combination chemotherapy in metastatic carcinoma of the breast Results with a three-drug combination

✍ Peter T. Otis; Steven A. Armentrout 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

PALA, vindesine, and cisplatin combinati

PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study

✍ Holger Voigt; Ulrich R. Kleeberg 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

Recombinant interferon alfa-2a in advanc

Recombinant interferon alfa-2a in advanced malignant melanoma. a phase i-ii study in combination with dtic

✍ G. R. C. McLeod; D. B. Thomson; P. Hersey 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 384 KB

There is a rising incidence of malignant melanoma world-wide and, despite major improvements in i t s early diagnosis and treatment, the 10-year death rate remains at 20-25%. Evidence that the immune system has a role in the control of melanoma growth has encouraged immunological intervention. The r